 |
 |
 |
 |
 |
|
|
|
|
|
Chairman - Audit Committee
Thomas R. Testman has served as a director since May 2003. Mr. Testman is a former managing partner of Ernst & Young, LLP where, during his tenure from 1962 to 1992, he served as managing partner of both Health Care Services and Management Consulting Services for the West Coast and national practices. From 1993 to the present, Mr. Testman has been serving as a board member to both public and private companies. In addition to serving on the Company's board, Mr. Testman currently serves on the board of directors of three other public companies, Amylin Pharmaceuticals, Inc., ChromaVision Medical Systems, Inc., and Specialty Laboratories, Inc. He also serves on the board of several private companies, including serving as chairman of Covenant Care, Inc. and Pacific Health Corporation. During 1998, he served as chairman of the board and interim Chief Executive Officer of Techniclone Corporation (now Peregrine Pharmaceuticals, Inc.). Mr. Testman previously was a director and a chairman of the Audit Committee of MiniMed Inc., and Mr. Testman also was chairman of the special committee that oversaw MiniMed's acquisition by Medtronic, Inc. He received a B.A. in Business from Pacific Union College and an M.B.A. from Trinity University. Mr. Testman is a certified public accountant.
Member - Compensation Committee
Member - Nominating & Governance Committee
John R. Daniels M.D. has served as a director on the Endocare board since February 2004. Dr. Daniels has taken a number of medical ideas and technologies from the laboratories of the academic world through the business planning stage to the successful launch and growth of corporations based on those ideas. He is currently Chairman of Balance Pharmaceuticals, a company he founded in 1992. From 1997 until 2002, Dr. Daniels was Chairman of Cohesion Technologies, which was sold to Angiotech Pharmaceuticals in January 2003. From 1985 to 1989, he was the Chief Executive Officer of Target Therapeutics. Dr. Daniels was a founder of Collagen Corporation in 1975 serving as vice-president for scientific and technical affairs from 1978-79 and continuing as a Director through 1998. On the academic side, Dr. Daniels has been an Associate Professor of Radiology (Courtesy) at the University of Southern California (USC) School of Medicine, since 1990 and he has been an Associate Professor of Medicine, Division of Oncology at the USC School of Medicine since 1979. From 1970 to 1979, Dr. Daniels taught in the Division of Oncology at the Stanford University School of Medicine as an instructor, assistant professor and clinical associate professor. He served his internship and residency in the Department of Medicine at the Stanford University School of Medicine. From 1966 to 1969, Dr. Daniels was a Research Associate in the National Institute of Dental Research at the National Institutes of Health. Dr. Daniels received his Bachelor of Arts from the Stanford University Department of Biology and his Doctor of Medicine from the Stanford University School of Medicine.
Member - Audit Committee
David L. Goldsmith was elected as a director in June 2005 and is a financial services veteran of more than three decades. Mr. Goldsmith is currently a business consultant principally focused in the areas of corporate finance. From 1999 to 2003, he was a managing director of venture capital for RS Investments. Mr. Goldsmith was a partner and managing director for Robertson Stephens and Company from 1991 to 1999. Prior to Robertson Stephens, he served as an associate director of research for BA Investment Management from 1978 to 1991. Before that, Mr. Goldsmith was a buy-side healthcare research analyst at Lehman Management from 1972 to 1978. Mr. Goldsmith currently serves on the Board of Directors of Apria Healthcare Group, AirLogix Inc. and Paradigm Health. Mr. Goldsmith holds a B.A. in Economics from Occidental College in Los Angeles and an M.B.A. from Columbia Graduate School of Business.
Chairman - Compensation Committee
Eric S. Kentor, Esq. was appointed to Endocare's Board on February 23, 2005. Kentor, an attorney, has both operational and legal experience in the healthcare industry and is well versed in the governance of public companies.
Kentor, 45, currently serves as an independent business consultant, primarily to healthcare technology companies. From 1995 until 2001, he was Senior Vice President, General Counsel and Corporate Secretary of Northridge, California-based MiniMed Inc., a world leader in the design, development, manufacture and marketing of advanced systems for the treatment of diabetes, which was purchased by Minneapolis-based Medtronic, Inc., in 2001. In addition to his responsibilities as Chief Legal Officer, Kentor served as an original and permanent member of MiniMed's Executive Management Committee, which was charged with overseeing the day-to-day operations of the company and executing its corporate strategic plan. Kentor joined MiniMed prior to its initial public offering and served continuously through completion of its acquisition by Medtronic. During his tenure, MiniMed grew from 260 employees and an $80 million valuation, to approximately 1,700 employees and $3.3 billion valuation.
Prior to joining MiniMed, Kentor was Vice President of Legal Services for Health Net, California's second largest health maintenance organization (HMO), where he held various positions beginning in 1994. From March 1994 until May 1995, Kentor also served as Executive Counsel of Health Net's parent corporation. Prior to Health Net, Kentor practiced with the law firm of McDermott, Will & Emery, where he was elected partner.
Kentor received a Juris Doctorate from the UCLA School of Law and a Bachelor of Arts in Political Science from UCLA. He lives in Bell Canyon, California with his family.
© 2009 Healthtronics, Inc. All rights reserved.